| . | . | Thermal energy ablation . | . | ||
|---|---|---|---|---|---|
| . | PFA n = 20 . | Total n = 39 . | RFA n = 29 . | Balloon ablation n = 10 (Cryo n = 6, VGLB n = 4) . | P-value* . |
| Age, years ± SD | 56.9 ± 11.0 | 66.1 ± 9.3 | 66.4 ± 8.4 | 65.1 ± 12.1 | 0.001 |
| Male | 15 (75.0) | 25 (64.1) | 19 (65.5) | 6 (60.0) | 0.40 |
| LA diameter, mm ± SD | 41.7 ± 5.0 | 41.1 ± 6.0 (n = 32) | 41.4 ± 6.4 (n = 27) | 39.6 ± 3.8 (n = 5) | 0.39 |
| LVEF, % ± SD | 63.6 ± 3.7 | 60.8 ± 7.5 (n = 35) | 60.9 ± 7.8 (n = 28) | 60.6 ± 6.7 (n = 7) | 0.07 |
| Hypertension | 13 (65.0) | 24 (61.5) | 20 (69.0) | 4 (40.0) | 0.80 |
| Diabetes | 2 (10.0) | 5 (12.8) | 3 (10.3) | 2 (20.0) | 1 |
| Stroke or TIA | 1 (5.0) | 2 (5.1) | 2 (6.9) | 0 (0) | 1 |
| CAD (MI/CABG) | 0 (0.0) | 2 (5.1) | 2 (6.9) | 0 (0) | 0.54 |
| Left common PV | 2 (10.0) | 4 (10.3) | 3 (10.3) | 1 (10) | 1 |
| Redo procedure date, day (IQR) | 84 (69–90) | 758 (319–1287) (n = 37) | 708 (310–1326) (n = 28) | 821 (316–1622) (n = 9) | <0.001 |
| . | . | Thermal energy ablation . | . | ||
|---|---|---|---|---|---|
| . | PFA n = 20 . | Total n = 39 . | RFA n = 29 . | Balloon ablation n = 10 (Cryo n = 6, VGLB n = 4) . | P-value* . |
| Age, years ± SD | 56.9 ± 11.0 | 66.1 ± 9.3 | 66.4 ± 8.4 | 65.1 ± 12.1 | 0.001 |
| Male | 15 (75.0) | 25 (64.1) | 19 (65.5) | 6 (60.0) | 0.40 |
| LA diameter, mm ± SD | 41.7 ± 5.0 | 41.1 ± 6.0 (n = 32) | 41.4 ± 6.4 (n = 27) | 39.6 ± 3.8 (n = 5) | 0.39 |
| LVEF, % ± SD | 63.6 ± 3.7 | 60.8 ± 7.5 (n = 35) | 60.9 ± 7.8 (n = 28) | 60.6 ± 6.7 (n = 7) | 0.07 |
| Hypertension | 13 (65.0) | 24 (61.5) | 20 (69.0) | 4 (40.0) | 0.80 |
| Diabetes | 2 (10.0) | 5 (12.8) | 3 (10.3) | 2 (20.0) | 1 |
| Stroke or TIA | 1 (5.0) | 2 (5.1) | 2 (6.9) | 0 (0) | 1 |
| CAD (MI/CABG) | 0 (0.0) | 2 (5.1) | 2 (6.9) | 0 (0) | 0.54 |
| Left common PV | 2 (10.0) | 4 (10.3) | 3 (10.3) | 1 (10) | 1 |
| Redo procedure date, day (IQR) | 84 (69–90) | 758 (319–1287) (n = 37) | 708 (310–1326) (n = 28) | 821 (316–1622) (n = 9) | <0.001 |
CABG, coronary artery bypass grafting; CAD, coronary artery disease; LA, left atrium; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PFA, pulsed field ablation; PV, pulmonary vein; RFA, radiofrequency ablation; VGLB, visually guided laser balloon.
Data shown as number (%) unless otherwise specified.
P-value compares PFA (n = 20) vs. thermal energy ablation (n = 39).
| . | . | Thermal energy ablation . | . | ||
|---|---|---|---|---|---|
| . | PFA n = 20 . | Total n = 39 . | RFA n = 29 . | Balloon ablation n = 10 (Cryo n = 6, VGLB n = 4) . | P-value* . |
| Age, years ± SD | 56.9 ± 11.0 | 66.1 ± 9.3 | 66.4 ± 8.4 | 65.1 ± 12.1 | 0.001 |
| Male | 15 (75.0) | 25 (64.1) | 19 (65.5) | 6 (60.0) | 0.40 |
| LA diameter, mm ± SD | 41.7 ± 5.0 | 41.1 ± 6.0 (n = 32) | 41.4 ± 6.4 (n = 27) | 39.6 ± 3.8 (n = 5) | 0.39 |
| LVEF, % ± SD | 63.6 ± 3.7 | 60.8 ± 7.5 (n = 35) | 60.9 ± 7.8 (n = 28) | 60.6 ± 6.7 (n = 7) | 0.07 |
| Hypertension | 13 (65.0) | 24 (61.5) | 20 (69.0) | 4 (40.0) | 0.80 |
| Diabetes | 2 (10.0) | 5 (12.8) | 3 (10.3) | 2 (20.0) | 1 |
| Stroke or TIA | 1 (5.0) | 2 (5.1) | 2 (6.9) | 0 (0) | 1 |
| CAD (MI/CABG) | 0 (0.0) | 2 (5.1) | 2 (6.9) | 0 (0) | 0.54 |
| Left common PV | 2 (10.0) | 4 (10.3) | 3 (10.3) | 1 (10) | 1 |
| Redo procedure date, day (IQR) | 84 (69–90) | 758 (319–1287) (n = 37) | 708 (310–1326) (n = 28) | 821 (316–1622) (n = 9) | <0.001 |
| . | . | Thermal energy ablation . | . | ||
|---|---|---|---|---|---|
| . | PFA n = 20 . | Total n = 39 . | RFA n = 29 . | Balloon ablation n = 10 (Cryo n = 6, VGLB n = 4) . | P-value* . |
| Age, years ± SD | 56.9 ± 11.0 | 66.1 ± 9.3 | 66.4 ± 8.4 | 65.1 ± 12.1 | 0.001 |
| Male | 15 (75.0) | 25 (64.1) | 19 (65.5) | 6 (60.0) | 0.40 |
| LA diameter, mm ± SD | 41.7 ± 5.0 | 41.1 ± 6.0 (n = 32) | 41.4 ± 6.4 (n = 27) | 39.6 ± 3.8 (n = 5) | 0.39 |
| LVEF, % ± SD | 63.6 ± 3.7 | 60.8 ± 7.5 (n = 35) | 60.9 ± 7.8 (n = 28) | 60.6 ± 6.7 (n = 7) | 0.07 |
| Hypertension | 13 (65.0) | 24 (61.5) | 20 (69.0) | 4 (40.0) | 0.80 |
| Diabetes | 2 (10.0) | 5 (12.8) | 3 (10.3) | 2 (20.0) | 1 |
| Stroke or TIA | 1 (5.0) | 2 (5.1) | 2 (6.9) | 0 (0) | 1 |
| CAD (MI/CABG) | 0 (0.0) | 2 (5.1) | 2 (6.9) | 0 (0) | 0.54 |
| Left common PV | 2 (10.0) | 4 (10.3) | 3 (10.3) | 1 (10) | 1 |
| Redo procedure date, day (IQR) | 84 (69–90) | 758 (319–1287) (n = 37) | 708 (310–1326) (n = 28) | 821 (316–1622) (n = 9) | <0.001 |
CABG, coronary artery bypass grafting; CAD, coronary artery disease; LA, left atrium; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PFA, pulsed field ablation; PV, pulmonary vein; RFA, radiofrequency ablation; VGLB, visually guided laser balloon.
Data shown as number (%) unless otherwise specified.
P-value compares PFA (n = 20) vs. thermal energy ablation (n = 39).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
